Home533573 • BOM
add
Alembic Pharmaceuticals Ltd
Previous close
₹1,018.90
Day range
₹1,017.45 - ₹1,035.45
Year range
₹710.50 - ₹1,296.15
Market cap
202.20B INR
Avg Volume
10.92K
P/E ratio
31.21
Dividend yield
1.07%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 16.48B | 3.33% |
Operating expense | 10.50B | 5.77% |
Net income | 1.53B | 12.34% |
Net profit margin | 9.31 | 8.76% |
Earnings per share | 7.24 | 4.10% |
EBITDA | 2.39B | 14.92% |
Effective tax rate | 15.12% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.29B | -12.75% |
Total assets | 72.30B | 12.01% |
Total liabilities | 23.43B | 18.00% |
Total equity | 48.88B | — |
Shares outstanding | 196.93M | — |
Price to book | 4.10 | — |
Return on assets | — | — |
Return on capital | 7.48% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.53B | 12.34% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1907
Employees
14,858
